Ignite Creation Date:
2024-05-06 @ 6:27 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05664139
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-08
First Post:
2022-12-08
Brief Title:
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Organization Data
Organization:
Fujian Cancer Hospital
Class:
OTHER_GOV
Study ID:
FJCH-HR-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fujian Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| SunWay Biotech Co LTD | INDUSTRY |
| Jiangsu Hengrui Pharmaceutical Co Ltd | INDUSTRY |